Send us Feedback

Alnylam Pharmaceuticals (ALNY)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 200M 195M 227M 148M 98.1M
Short Term Investments 223M 239M 181M 119M 120M
Accounts Receivable 24.1M 4.19M 5.83M 5.86M 5.02M
Inventories 0 0 0 0 0
Pre-paid Expenses 4.52M 4.67M 5.45M 5.33M 5.17M
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 452M 442M 419M 278M 228M
Property, Plant & Equipment 19.6M 19.2M 19.3M 18.5M 18.2M
Goodwill & Intangibles 838K 795K 751K 708K 665K
Other Long-term Assets 108M 87.1M 110M 215M 243M
Total Long-Term Assets 128M 112M 135M 240M 268M
Total Assets 580M 555M 555M 519M 496M
Accounts Payable 3.34M 2.59M 8.73M 6.46M 8.43M
Accrued Expenses 9.86M 0 0 0 0
Short Term Debt 3.23M 0 0 0 0
Other Current Liabilities 85.6M 87.5M 85.1M 86.0M 84.3M
Total Current Liabilities 102M 99.5M 104M 102M 101M
Long Term Debt 719K 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 2.73M 2.34M 1.95M 2.64M
Other Long-term Liabilities 273M 250M 249M 230M 210M
Total Long-term Liabilities 274M 253M 252M 232M 213M
Minority Interest 0 0 0 0 0
Total Liabilities 376M 353M 356M 334M 314M
Preferred Stock 0 0 0 0 0
Common Par 414K 414K 414K 417K 418K
Additional Paid-In Capital 448M 453M 458M 465M 472M
Retained Earnings -243M -252M -260M -283M -292M
Treasury Stock 0 0 0 0 0
Other Equity -1.10M 1.19M 623K 1.62M 1.89M
Total Shareholder's Equity 205M 202M 199M 184M 182M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki